TABLE 5.
Adverse eventa | No. (%) reporting the event
|
||
---|---|---|---|
908 1,395 mg (n = 26) | 908 1,860 mg (n = 29) | APV 1,200 mg (n = 23) | |
Any event | 13 (50) | 11 (38) | 9 (39) |
Diarrhea | 3 (12) | 2 (7) | 4 (17) |
Sleep disorder | 3 (12) | 1 (3) | 0 |
Hypersensitivity reaction to abacavir | 2 (8) | 2 (7) | 1 (4) |
Vomiting | 2 (8) | 1 (3) | 1 (4) |
Fever | 2 (8) | 1 (3) | 0 |
Rash | 2 (8) | 1 (3) | 0 |
Mood disorder | 2 (8) | 0 | 0 |
Nausea | 1 (4) | 2 (7) | 5 (22) |
Headache | 1 (4) | 2 (7) | 0 |
Fatigue | 1 (4) | 1 (3) | 3 (13) |
Abdominal pain | 1 (4) | 0 | 4 (17) |
Decreased white cells | 0 | 3 (10) | 0 |
Events listed were reported in ≥5% of any group (treatment period 1).